ICU Medical Completes Acquisition of Pfizer's Hospira Infusion Business
The $1bn in cash and stock deal will create a pure-play infusion therapy company with estimated revenue of about $1.45bn.
The $1bn in cash and stock deal will create a pure-play infusion therapy company with estimated revenue of about $1.45bn.